Intrinsiqq
Cumberland Pharmaceuticals Inc. logo

Cumberland Pharmaceuticals Inc. Insider Trading

CPIX

⊜ Compare
Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Aug 2025.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
Aug 2025
Aug 29, 2025

Get an email when CPIX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Aug 1, 2025 – Aug 29, 2025
    Caroline Young
    Director · bought 121 at avg $3.29
    $398
    0.4% of stake
  • Aug 1, 2025 – Aug 29, 2025
    James Jones
    Director · bought 262 at avg $3.29
    $862
    0.6% of stake
  • Aug 1, 2025 – Aug 29, 2025
    A J Kazimi
    Chairman and CEO · bought 262 at avg $3.29
    $862
    <0.1% of stake
  • Aug 1, 2025 – Aug 29, 2025
    Kenneth Krogulski
    Director · bought 1,372 at avg $3.29
    5K
    0.5% of stake
  • Jul 1, 2025 – Jul 31, 2025
    Caroline Young
    Director · bought 168 at avg $3.44
    $578
    0.5% of stake
  • Jul 1, 2025 – Jul 31, 2025
    James Jones
    Director · bought 340 at avg $3.43
    1K
    0.8% of stake
  • Jul 1, 2025 – Jul 31, 2025
    A J Kazimi
    Chairman and CEO · bought 340 at avg $3.43
    1K
    <0.1% of stake
  • Jul 1, 2025 – Jul 31, 2025
    Kenneth Krogulski
    Director · bought 1,712 at avg $3.43
    6K
    0.6% of stake
  • Jun 2, 2025 – Jun 30, 2025
    Caroline Young
    Director · bought 84 at avg $4.80
    $404
    0.3% of stake
  • Jun 2, 2025 – Jun 30, 2025
    A J Kazimi
    Chairman and CEO · bought 168 at avg $4.80
    $807
    <0.1% of stake
  • Jun 2, 2025 – Jun 30, 2025
    James Jones
    Director · bought 168 at avg $4.80
    $807
    0.4% of stake
  • Jun 2, 2025 – Jun 30, 2025
    Kenneth Krogulski
    Director · bought 935 at avg $4.83
    5K
    0.3% of stake
  • May 1, 2025 – May 30, 2025
    Kenneth Krogulski
    Director · bought 945 at avg $5.11
    5K
    0.3% of stake
  • May 1, 2025 – May 30, 2025
    James Jones
    Director · bought 168 at avg $5.11
    $858
    0.4% of stake
  • May 1, 2025 – May 30, 2025
    Caroline Young
    Director · bought 84 at avg $5.11
    $429
    0.3% of stake
  • May 1, 2025 – May 30, 2025
    A J Kazimi
    Chairman and CEO · bought 168 at avg $5.11
    $858
    <0.1% of stake
  • Apr 1, 2025 – Apr 30, 2025
    Caroline Young
    Director · bought 93 at avg $4.48
    $417
    0.3% of stake
  • Apr 1, 2025 – Apr 30, 2025
    James Jones
    Director · bought 186 at avg $4.48
    $833
    0.4% of stake
  • Apr 1, 2025 – Apr 30, 2025
    A J Kazimi
    Chairman and CEO · bought 186 at avg $4.48
    $833
    <0.1% of stake
  • Apr 1, 2025 – Apr 30, 2025
    Kenneth Krogulski
    Director · bought 1,035 at avg $4.48
    5K
    0.4% of stake
  • Mar 3, 2025 – Mar 31, 2025
    Caroline Young
    Director · bought 74 at avg $5.18
    $384
    0.2% of stake
  • Mar 3, 2025 – Mar 31, 2025
    James Jones
    Director · bought 168 at avg $5.24
    $881
    0.4% of stake
  • Mar 3, 2025 – Mar 31, 2025
    A J Kazimi
    Chairman and CEO · bought 168 at avg $5.24
    $881
    <0.1% of stake
  • Mar 3, 2025 – Mar 31, 2025
    Kenneth Krogulski
    Director · bought 875 at avg $5.20
    5K
    0.3% of stake
  • Dec 2, 2024 – Dec 20, 2024
    Caroline Young
    Director · bought 154 at avg $1.66
    $256
    0.5% of stake
  • Dec 2, 2024 – Dec 20, 2024
    James Jones
    Director · bought 769 at avg $1.71
    1K
    2.0% of stake
  • Dec 2, 2024 – Dec 20, 2024
    A J Kazimi
    Chairman and CEO · bought 769 at avg $1.71
    1K
    <0.1% of stake
  • Dec 2, 2024 – Dec 20, 2024
    Kenneth Krogulski
    Director · bought 4,716 at avg $1.74
    8K
    1.7% of stake
  • Nov 6, 2024 – Nov 29, 2024
    Caroline Young
    Director · bought 546 at avg $1.17
    $637
    1.9% of stake
  • Nov 6, 2024 – Nov 29, 2024
    James Jones
    Director · bought 1,305 at avg $1.16
    2K
    3.4% of stake
  • Nov 6, 2024 – Nov 29, 2024
    A J Kazimi
    Chairman and CEO · bought 1,305 at avg $1.16
    2K
    <0.1% of stake
  • Nov 6, 2024 – Nov 29, 2024
    Kenneth Krogulski
    Director · bought 7,024 at avg $1.16
    8K
    2.7% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CPIX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with CPIX

CompareIntrinsic value
VSTMVerastem Inc.
$9.85+0.82%40
VRCAVerrica Pharmaceuticals Inc.
$3.46+5.02%40
CUECue Biopharma, Inc.
$19.84-4.89%40
JAGXJaguar Health, Inc.
$0.50-10.61%40
ARCTArcturus Therapeutics Holdings Inc.
$10.87+13.94%13
ZOMDFZomedica Corp.
$0.09-1.08%46
STOKStoke Therapeutics Inc.
$27.45+1.70%25
SBFMSunshine Biopharma Inc.
$2.65-3.28%40

Spot a number that looks wrong? Check it in CPIX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CPIX

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.